HCA Healthcare, Inc. $HCA Stock Sold by Intech Investment Management LLC

Intech Investment Management LLC reduced its position in HCA Healthcare, Inc. (NYSE:HCA – Free Report) by 51.3% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 54,727 shares of the company’s stock after selling 57,659 shares during the period. Intech Investment Management LLC’s holdings in HCA Healthcare were worth $23,354,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. BlackRock Inc. bought a new stake in HCA Healthcare in the 2nd quarter worth approximately $5,069,974,000. Wellington Management Group LLP boosted its position in shares of HCA Healthcare by 20.5% during the 2nd quarter. Wellington Management Group LLP now owns 4,707,473 shares of the company’s stock valued at $1,835,397,000 after acquiring an additional 799,761 shares during the last quarter. Darsana Capital Partners LP grew its holdings in shares of HCA Healthcare by 46.7% in the second quarter. Darsana Capital Partners LP now owns 1,100,000 shares of the company’s stock valued at $428,879,000 after purchasing an additional 350,000 shares in the last quarter. Legal & General Group Plc bought a new stake in HCA Healthcare in the second quarter worth $410,992,000. Finally, Jupiter Topco LLC bought a new stake in HCA Healthcare in the second quarter worth $371,138,000. 62.73% of the stock is owned by institutional investors.

HCA Healthcare Stock Down 0.0%

Shares of HCA opened at $498.82 on Monday. The business has a fifty day moving average of $452.79 and a 200 day moving average of $445.91. The company has a market cap of $104.20 billion, a PE ratio of 16.53, a P/E/G ratio of 1.67 and a beta of 1.11. HCA Healthcare, Inc. has a 52-week low of $353.99 and a 52-week high of $556.52.

HCA Healthcare (NYSE:HCA – Get Free Report) last posted its quarterly earnings data on Tuesday, October 27th. The company reported $7.22 earnings per share for the quarter, beating analysts’ consensus estimates of $6.65 by $0.57. HCA Healthcare had a net margin of 8.61% and a negative return on equity of 198.52%. The business had revenue of $19.85 billion for the quarter, compared to analysts’ expectations of $19.33 billion. During the same quarter in the previous year, the business posted $6.96 earnings per share. The business’s revenue was up 3.6% compared to the same quarter last year. As a group, research analysts anticipate that HCA Healthcare, Inc. will post 30.14 earnings per share for the current fiscal year.

HCA Healthcare Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Tuesday, December 29th. Investors of record on Tuesday, December 15th will be issued a dividend of $0.78 per share. This represents a $3.12 annualized dividend and a yield of 0.6%. The ex-dividend date is Tuesday, December 15th. HCA Healthcare’s dividend payout ratio is presently 10.34%.

Key HCA Healthcare News

These are some of the HCA news items that stood out recently:

  • Positive Sentiment: Value-focused articles describe HCA as a reasonably valued healthcare stock with long-term earnings-growth potential, supported by hospital demand and its scale. One analysis notes its valuation is below the sector median. Why HCA Healthcare is a Top Value Stock for the Long-Term
  • Negative Sentiment: A senior vice president reportedly sold about $1.77 million in HCA shares. Insider sales can weigh on sentiment, although a sale alone does not establish a negative outlook. Insider selling at HCA Healthcare
  • Negative Sentiment: Pomerantz LLP announced an investigation into claims on behalf of HCA investors. The announcement does not establish wrongdoing, but the added legal uncertainty could concern investors. Pomerantz investigation announcement

Insider Buying and Selling

In other news, SVP Erica Rossitto sold 3,500 shares of the company’s stock in a transaction that occurred on Tuesday, November 10th. The stock was sold at an average price of $505.81, for a total transaction of $1,770,335.00. Following the transaction, the senior vice president owned 13,426 shares of the company’s stock, valued at approximately $6,791,005.06. This represents a 20.68% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, COO Jon M. Foster sold 21,713 shares of the stock in a transaction that occurred on Friday, November 6th. The stock was sold at an average price of $494.95, for a total value of $10,746,849.35. Following the completion of the sale, the chief operating officer owned 10,000 shares in the company, valued at approximately $4,949,500. The trade was a 68.47% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 36,413 shares of company stock valued at $18,251,464 in the last ninety days. 1.50% of the stock is owned by company insiders.

Wall Street Analysts Forecast Growth

Several equities analysts have commented on the stock. Deutsche Bank set a $476.00 price objective on shares of HCA Healthcare in a research report on Monday, July 27th. Leerink Partners restated an “outperform” rating and issued a $492.00 target price on shares of HCA Healthcare in a report on Friday, September 18th. The Goldman Sachs Group decreased their target price on shares of HCA Healthcare from $558.00 to $485.00 and set a “buy” rating on the stock in a research report on Tuesday, July 28th. Royal Bank Of Canada increased their price target on shares of HCA Healthcare from $496.00 to $521.00 and gave the company an “outperform” rating in a report on Friday, October 30th. Finally, KeyCorp lifted their price target on HCA Healthcare from $435.00 to $490.00 and gave the stock an “overweight” rating in a research report on Wednesday, October 28th. Sixteen research analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $480.13.

Read Our Latest Stock Report on HCA Healthcare

About HCA Healthcare

(Free Report)

HCA Healthcare is a healthcare services company that operates hospitals and other care facilities. Its services include inpatient and outpatient care, emergency treatment, surgery, diagnostic services and specialized care across areas such as cancer and cardiovascular medicine. The company serves patients in the United States and the United Kingdom through its network of hospitals and outpatient facilities, including surgery centers, urgent care clinics and physician practices. Founded in 1968, HCA Healthcare is headquartered in Nashville, Tennessee.

Read More

Institutional Ownership by Quarter for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.